According to Carisma Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.16952.
At the end of 2023 the company had a P/S ratio of 7.93.
P/S ratio history for Carisma Therapeutics from 2023 to 2023